Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 1580-1583, April 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ecsedy, J. A.
Right arrow Articles by Seyfried, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ecsedy, J. A.
Right arrow Articles by Seyfried, T. N.

Ganglioside Biosynthetic Gene Expression in Experimental Mouse Brain Tumors1

J. A. Ecsedy, M. G. Manfredi, H. C. Yohe and T. N. Seyfried2

Department of Biology, Boston College, Chestnut Hill, Massachusetts 02167-3811 [J. A. E., M. G. M., T. N. S.]; VA Medical and Regional Office Center, White River Junction, Vermont 05009 [H. C. Y.]; and Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire 03755 [H. C. Y.]

The genes for cytidine monophospho-N-acetylneuraminic acid hydroxylase (NeuAc-H) and ß-1,4-N-acetylgalactosaminyl transferase (GalNAc-T)were examined using reverse transcription-PCR in two experimental mouse brain tumors, EPEN and CT-2A. NeuAc-H is required for the synthesis of gangliosides containing N-glycolylneuraminic acid, whereas GalNAc-T is required for the synthesis of ganglioside GM2. The genes were analyzed in solid tumors grown in vivo and in tumor cells grown in vitro. NeuGc-containing gangliosides are abundant in cells of the mouse immune system, including macrophages, but are undetectable in normal mouse brain. GM2 is expressed in both neural and nonneural mouse cells and tissues. The EPEN tumor cells synthesize only ganglioside GM3, whereas the CT-2A tumor cells synthesize GM3, GM2, GM1, and GD1a. NeuAc-H gene expression was detected in both solid tumors grown in vivo but was undetectable in either tumor cell line. The presence or absence of NeuAc-H gene expression in the tumor tissues and cells correlates with the presence or absence, respectively, of NeuGc-containing gangliosides. Differences in GalNAc-T gene expression between the solid tumors and the cultured tumor cells correlate with the expression of ganglioside GM2. The findings suggest that the differences in ganglioside biosynthetic gene expression between brain tumors grown in vivo and in vitro are associated with the presence or absence, respectively, of tumor-infiltrating host cells.

1 Supported by NIH Grant NS24826, the Boston College Research Expense Fund, and a VA Merit Review (to H. C. Y.).

2 To whom requests for reprints should be addressed. Phone: (617) 552-3563; Fax: (617) 552-2011; E-mail: seyfried@hermes.bc.edu.

Received 12/23/96. Accepted 2/17/97.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. G. Manfredi, S. Lim, K. P. Claffey, and T. N. Seyfried
Gangliosides Influence Angiogenesis in an Experimental Mouse Brain Tumor
Cancer Res., October 1, 1999; 59(20): 5392 - 5397.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. A. Ecsedy, H. C. Yohe, A. J. Bergeron, and T. N. Seyfried
Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors
J. Lipid Res., November 1, 1998; 39(11): 2218 - 2227.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
H.-H. Chou, H. Takematsu, S. Diaz, J. Iber, E. Nickerson, K. L. Wright, E. A. Muchmore, D. L. Nelson, S. T. Warren, and A. Varki
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence
PNAS, September 29, 1998; 95(20): 11751 - 11756.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.